China Taiping Insurance Holdings Company Limited Overview
China Taiping is the Hong Kong-listed flagship of China Taiping Insurance Group, the only centrally administered Chinese state-owned financial group headquartered in Hong Kong. It is a diversified insurance conglomerate whose economics are dominated by Taiping Life (TPL), a top-ten Chinese life insurer with a 4.1–4.2% market share, complemented by domestic P&C (Taiping General, ~1.9% share), pensions (Taiping Pension), Hong Kong-based global reinsurance (Taiping Re), overseas P&C franchises in Hong Kong, Macau, Singapore, Indonesia, the UK and Luxembourg, and a HK$2.8 trillion-plus asset management platform. In 2025 it delivered record profit of HK$27.1bn and a 251% dividend increase, and in H1 2026 profit rose 90%. It differentiates through cross-border Greater Bay Area capabilities, an early and near-complete pivot to participating life products (97.8% of first-year regular premium), and policy alignment as a "Hong Kong-based central financial enterprise". It trades at roughly 0.3x embedded value.
What the company does
CTIH is an investment holding company whose subsidiaries underwrite direct life insurance, property and casualty insurance and all classes of reinsurance, and provide asset management, pension administration, insurance brokerage, financial leasing, property investment and securities brokerage services [IR26 Note 3]. The Group defines three major business segments—life, P&C and reinsurance—supported by investment holding, asset management, pension and other businesses [AR25 – Embedded Value background].
Company's own description (paraphrased from AR25/IR26)
Management describes China Taiping as pursuing "high-quality development" around four 2026 priorities—"Risk Prevention, Management Excellence, Growth Acceleration, Safety Assurance"—with a ten-year ambition to become a "first-class insurance group" by systematically upgrading talent, professional capabilities, risk management, customer service, technology and governance. It positions itself as a Hong Kong-based central financial enterprise serving national strategies: Greater Bay Area integration, Hong Kong's status as an international financial centre, the Belt and Road Initiative and the "Five Target Areas" of finance (technology, green, inclusive, ageing and digital finance) [AR25 Chairman's Statement].
Revenue model
| Component | FY2024 (HKD Mn) | FY2025 (HKD Mn) | Share of FY2025 total | Source |
|---|---|---|---|---|
| Insurance revenue | 111,268 | 112,267 | 62.7% | [AR25] |
| Total investment income (incl. associates) | 66,543 | 66,826 | 37.3% | [AR25] |
| Sum (gross revenue proxy, before insurance finance expenses) | 177,811 | 179,093 | 100% | derived |
| Revenue character | Principal entities | Indicative weight |
|---|---|---|
| Long-term protection & savings (CSM release, investment spread) | TPL, TPL (HK), TP Singapore life, TPP | Life insurance revenue HK$64.3bn = ~57% of FY2025 insurance revenue before eliminations |
| Short-term risk transfer (premium earned) | TPI, CTPI (HK), TP Macau, TP UK, TP Singapore, TP Indonesia | ~36% (TPI HK$34.2bn + overseas P&C HK$5.8bn) |
| Reinsurance | TPRe, TPRe (China) | ~8% (HK$8.9bn) |
| Fee income | TPAM, TP Fund, TPCA, TPFH, TPP | HK$3.6bn management fees (outside insurance revenue) |
| Spread/financing income | TSFL (financial leasing), property | Finance lease receivables HK$40.5bn (30 Jun 2026) |
As an insurer reporting under HKFRS 17, "revenue" has two components:
Within insurance revenue, the model is predominantly long-duration contract service: the release of contractual service margin (CSM), risk adjustment and expected claims on life policies, plus earned premium on short-duration P&C business measured under the premium allocation approach (PAA). Fee-based income comes from asset management (HK$3.60bn management fees in FY2025), pension administration and intermediary services. There is no product-licensing or subscription component in the conventional sense.
Value-chain position and customers
China Taiping is a full-stack primary insurer: it manufactures products, distributes them through captive agents (172,003 TPL individual agents at 30 Jun 2026), bank partners (91,977 bancassurance outlets), telemarketing/internet and direct corporate sales (9,840 TPI direct representatives), retains and cedes risk (including to its own reinsurer), and manages the resulting asset pools in-house via TPAM. Customers include 12.9 million TPL individual customers, 20.8 million TPI individual and 0.72 million corporate customers, 126 group-level "strategic clients" (state-owned and large enterprises), governments (Hui Min Bao city health schemes, long-term care insurance, critical illness for urban/rural residents, HKSAR residential care scheme), and ceding insurers worldwide [IR26].
End-markets
Chinese Mainland life & health (dominant), Chinese Mainland P&C (motor 53% of TPI direct premium), pensions (second-pillar enterprise/occupational annuities, third-pillar personal pensions), Hong Kong and Macau life and P&C, Southeast Asian P&C, UK/European niche P&C, and global P&C/life reinsurance. Approximately 92% of total income came from Mainland China in H1 2026 (H1 2025: 89%) [IR26 Note 2].
Independent characterisation
Economically, CTIH is a leveraged, rate-sensitive Chinese life insurer with a holding-company wrapper. TPL contributed 94% of segment after-tax profit in FY2025, and life insurance assets account for 87% of group assets. Group earnings are therefore driven by (i) CSM release, (ii) the spread between investment yields and guaranteed costs, and (iii) mark-to-market equity and bond movements flowing through profit and loss. The P&C, reinsurance and overseas businesses are strategically meaningful (diversification, Hong Kong policy role) but financially small. The 75.1% ownership of TPL (24.9% held by Ageas) and large perpetual and minority claims mean that only ~74% of operating profit reaches ordinary shareholders.
Strategy
Stated strategic themes (AR25 / IR26)
-
Core priorities 2026: "Risk Prevention. Management Excellence. Growth Acceleration. Safety Assurance."
-
Ten-year vision: become a "first-class insurance group" via six "first-class" capabilities—coverage, customer service, professional organisation, risk management, governance mechanisms and talent [IR26 Outlook].
-
15th Five-Year Plan (2026–2030): formulation and implementation of a group plan translating national priorities into subsidiary targets.
-
National-strategy roles: GBA as the "leading zone" for group development; supporting Hong Kong as an international financial centre and risk management centre; Belt and Road insurance for "going global" enterprises.
-
"Five Target Areas" of finance: technology, green, inclusive, ageing and digital finance.
-
Value transformation in life: participating products, agent productivity, "Aligning Sales Practices with Regulatory Filings" (报行合一).
-
Investment philosophy: "Long-term Investment, Value Investment and Responsible Investment"; acting as "patient capital"; higher allocation to high-quality equities and high-dividend stocks.
-
Ecosystem: Medical Health & Elder Care and Fintech Ecological Alliances; self-built elder care communities; insurance-investment linkage.
-
Prudent internationalisation and stronger asset-liability management against low domestic rates.
Initiatives in the last 24 months
| Initiative | Status / metrics | Source |
|---|---|---|
| Participating-product pivot at TPL | 86.1% of first-year regular premium (FY2025) → 97.8% (H1 2026) | [AR25, IR26] |
| Agent force restructuring | Agents fell from 226,102 to 166,704 (2025), then rose to 172,003; per-capita productivity RMB29,294 (+73.8%) | [AR25, IR26] |
| Equity allocation increase | Equity 13.9% (end-2024) → 17.3% (end-2025) → 18.9% (mid-2026); gold pilot | [AR25, IR26] |
| High-dividend equity strategy | Dividend income HK$6.9bn FY2025 (+29.4%) | [AR25] |
| Technology finance | Tech investment HK$141.2bn (mid-2026, +26.9% YTD); tech insurance premium HK$1.86bn FY2025 (+16.6%) | [AR25, IR26] |
| Green finance | Green premiums HK$6.26bn FY2025 (+17.5%); green investments HK$76.1bn | [AR25, IR26] |
| Ageing finance | Second-pillar AUM HK$765.9bn record; third-pillar premium +40.7% | [AR25] |
| AI/digital | "Zhi Xiang AI" product series, 50 scenarios (2025); "1+1+4" AI ecosystem; AI claims for life, AI injury-claims image assessment for motor; 24/7 group security monitoring | [AR25, IR26] |
| Elder care | Residents +57.6% (2025), +53% (H1 2026); 1,300+ Hong Kong seniors served; 120+ home-care experience centres | [AR25, IR26] |
| GBA | First "Southbound Travel for Guangdong Vehicles" policy; GBA retirement solution; TPL (HK) sole operator of HKSAR Residential Care Services Scheme in Guangdong medical subsidy pilot; first Southbound Bond Connect investment | [AR25, IR26] |
| Hong Kong IFC | Marine War Risks Insurance Pool; drone insurance; Hong Kong Flood Catastrophe Model; Northern Metropolis MoU (TPFH); catastrophe/climate risk labs | [AR25, IR26] |
| Cost reduction | Staff costs -5.1% in FY2025; headcount -4,315 | [AR25] |
| Capital | HK$9.75bn perpetual securities issued by subsidiary (2025); Ageas TPP injection | [AR25] |
Medium-term financial targets
CTIH has not publicly disclosed quantitative medium-term financial targets (ROE, NBV growth, payout ratio) in the documents reviewed. Guidance is qualitative: "effective qualitative improvement and reasonable quantitative growth" and a "strong start" to the 15th Five-Year Plan [AR25, IR26].
Products & Services
Note: CTIH does not publish a consolidated product catalogue with launch dates and pricing in its results filings; individual product terms (crediting rates, premium tables) are filed with the NFRA and on subsidiary websites. Items below are drawn from AR25/IR26 and identified press coverage. Pricing is not publicly disclosed at group level unless stated.
Life insurance segment
| Product line | Entity | Description & capabilities | Target customer | Scale/latest data |
|---|---|---|---|---|
| Participating (dividend) life & endowment | TPL | Savings-protection policies with guaranteed plus non-guaranteed bonuses; lower guaranteed rate sensitivity than traditional | Mass-affluent individuals via agents and banks | Direct premium HK$57.8bn FY2025 (+91.7%); HK$64.5bn H1 2026 (+76.4%); 97.8% of first-year regular premium in H1 2026 |
| Traditional life (whole life, increasing whole life) | TPL | Fixed guaranteed benefits; being de-emphasised as guaranteed rates fall | Legacy/high net worth | HK$81.4bn FY2025 (-13.5%); HK$35.8bn H1 2026 (-30.8%) |
| Long-term health (critical illness, long-term medical) | TPL | Protection products with morbidity risk | Families | HK$34.4bn FY2025 (-3.0%); HK$20.0bn H1 2026 (+2.6%) |
| Annuity | TPL | Deferred and immediate annuities; links to elder care community eligibility | Pre-retirees | HK$18.2bn FY2025 (-30.3%); HK$6.4bn H1 2026 (-47.7%) |
| Accident & short-term health | TPL | Short-duration accident and medical | Individuals, groups | HK$9.6bn FY2025; HK$6.4bn H1 2026 (+29.2%) |
| Universal life / investment-linked | TPL | Residual books | — | HK$21m combined FY2025 |
| Group insurance | TPL | Employee benefits (rising after TPP group business transfer) | Corporates | HK$683m FY2025; HK$2.34bn H1 2026 (+369.9%) |
| Elder-care-linked policies ("retirement community eligibility certificates") | TPL/TPIM | Policies granting priority access to China Taiping elder care communities | Affluent seniors | 26,800 certificates issued FY2025 driving HK$13.6bn new premium |
| "Exclusive + N" GBA life products | TPL (HK)/TPL | Cross-border products tailored to Greater Bay Area | GBA residents | Launched H1 2026 [IR26] |
| Cross-border legacy products (e.g., "Infinite Legacy") | TPL/TPL (HK)/TP Singapore | Multi-jurisdiction wealth transfer | HNW | — |
| Hong Kong life (savings, protection) | TPL (HK) | HK/Macau life business | HK residents, Mainland visitors | Direct premium HK$12.8bn FY2025 (-15.0%); HK$6.0bn H1 2026 (-26.2%) |
| Macau life (bancassurance, pension/CPF prep) | TPL (Macau) | Bank-channel life | Macau residents | — |
| Singapore life | TP Singapore | Life since 2018, moving to capital self-sustaining model | Singapore residents | HK$995m FY2025 (+27.6%); HK$426m H1 2026 (-23.1%) |
| Corporate/personal pension insurance; group life | TPP | Enterprise pension insurance (group business transferred to TPL in 2025) | Corporates | TPP direct premium HK$6.6bn FY2025 (-25.1%); HK$1.7bn H1 2026 (-57.1%) |
| Third-pillar individual pension | TPP | Tax-advantaged personal pension products | Individuals | HK$831m premium FY2025 (+40.7%) |
| Commercial pension | TPP | Commercial pension accounts | Individuals | AUM HK$20.5bn end-2025; >480,000 accounts |
PRC domestic P&C (TPI)
| Product line | Description | Scale |
|---|---|---|
| Motor (incl. new-energy vehicles) | Compulsory + commercial motor; NEV optimisation; profitability-first pricing | Direct premium HK$21.3bn FY2025 (+1.2%); HK$10.9bn H1 2026 (+4.7%); motor persistency +1.7pts H1 2026 |
| Non-marine (property, liability, engineering, health, agriculture, credit) | Technology insurance, green insurance, inclusive insurance | HK$13.4bn FY2025 (+7.0%); HK$9.0bn H1 2026 (+6.1%) |
| Marine | Cargo and hull | HK$833m FY2025; HK$568m H1 2026 (+30.5%) |
| Agricultural insurance | Crop and livestock | Group agricultural premium HK$1.20bn FY2025 (+17.0%); H1 2026 +14.7%, protection HK$18.0bn for 330,000 farmers |
| Government-linked health schemes | Hui Min Bao city supplementary health, critical illness for urban/rural residents, long-term care insurance services | Coverage 22m / 39m / 50m people respectively (H1 2026) |
| Cross-border motor ("Southbound Travel for Guangdong Vehicles"; GBA three-region motor) | First underwriting for Guangdong vehicles entering HK | 41,000 cross-border vehicles FY2025 (+5.6%) |
Overseas P&C
| Entity | Lines | FY2025 direct premium (HKD Mn) | FY2025 COR |
|---|---|---|---|
| CTPI (HK) | Commercial property, employees' compensation, motor, marine, drone, construction; Northern Metropolis projects; Hong Kong Marine War Risks Insurance Pool participant | 2,509 | 103.4% |
| TP Macau | Market leader (#1) in Macau P&C; SME catastrophe insurance for Macau government | 956 | 83.7% |
| TP UK | Niche P&C for Chinese enterprises and diaspora | 443 | 77.5% |
| TP Singapore (P&C) | Commercial lines for Chinese "going global" enterprises and local market | 874 | 94.1% |
| TP Indonesia | Chinese-enterprise and local business; first cross-border RMB reinsurance transaction (Jun 2026) | 631 | 95.2% |
| TP Luxembourg | EU platform for Chinese clients in Europe; started June 2024; initial stage | — | — |
Reinsurance
| Entity | Products | Scale |
|---|---|---|
| TPRe (Hong Kong) | Global P&C and life treaty/facultative; catastrophe reinsurance; leader in Hong Kong onshore property reinsurance; "General Reinsurer of the Year" (Asia Insurance Industry Awards 2025) | Total premium HK$16.3bn FY2025 (life 4.1bn; non-life 12.1bn); P&C COR 96.5% |
| TPRe (China) | Mainland reinsurance; Shanghai reinsurance operations centre | Included above |
| TPRB | Reinsurance and life brokerage | — |
| Catastrophe bond | Asia's first dual-risk, dual-trigger cat bond issued in Hong Kong | — |
Asset management, pensions and other
| Business | Entity | Description | AUM / scale |
|---|---|---|---|
| Insurance asset management | TPAM | Manages group RMB and non-RMB portfolios, third-party mandates | HK$1,763.8bn (30 Jun 2026) |
| Alternative investment | TPCA | Infrastructure/debt plans, PE; manages Medical & Health Fund and Innovation & Technology Fund | HK$85.7bn |
| Mutual funds | TP Fund | Public funds for retail/institutional | Included in TPAM fees |
| Hong Kong/overseas asset management | TPFH (incl. TPAM (HK)) | Non-RMB assets; Victoria Harbour Nexus Innovation LPF selected for HKSAR ITF Enhanced Scheme | HK$99.1bn |
| Annuity trustee & investment | TPP | Enterprise and occupational annuities (second pillar) | Second-pillar AUM HK$765.9bn end-2025; +15.3% in H1 2026; TPP total AUM HK$940.1bn |
| Financial leasing | TSFL | Leasing to strategic emerging industries | Finance lease receivables HK$40.5bn |
| Elder care communities | TPIM | China Taiping Wutong Home (Shanghai), Yulan Home (Beijing), Mumian Home (Guangzhou), Furong Home (Chengdu); home-based care (120+ experience centres, 20,000+ certificates) | 2,877 residents end-2025 (+57.6%); +53% in H1 2026 |
| Hengqin TCM Science & Technology Industrial Park | Group | Guangdong-Macau cooperation park | 82.5% occupancy end-2025 |
| Securities broking | TPFS | Hong Kong broking | — |
| Technology | Taiping Technology | Group IT/AI; "Zhi Xiang AI" product series; "1+1+4" AI ecosystem | 50 AI application scenarios (FY2025) |
| Customer service | Group | "China Taiping 95589" hotline and WeChat platform; "Lucky Elephant Festival" customer festival (7th edition from 17 Jul 2026) | ~7,500 events in 2025 festival |
Financial Narrative
Comparability warning: FY2021 is HKFRS 4; FY2022 is HKFRS 17 restated; FY2023–FY2025 are HKFRS 17. Insurance-company concepts of "gross profit", "EBITDA", "working capital" and "cash conversion cycle" are not meaningful and are presented as "not applicable" (NA) where so.
Income statement
Sources and notes: FY2024–FY2025 [AR25]. FY2022 restated profit (HK$4.297bn) and FY2023 (HK$6.190bn, +44.1%) are consistent with AR25/aggregator data; FY2022 as originally reported under HKFRS 4 was HK$2.797bn [AR22]—a discrepancy caused purely by restatement. FY2023 DPS HK$0.30 (+15%) per broker coverage, implying FY2022 HK$0.26 (derived). Insurance revenue FY2022–FY2023 per aggregator (matches FY2024–25 filings). Gross profit, operating income and EBITDA are NA for an insurer.
Margins and growth
Insurance revenue CAGR FY2022–FY2025: 1.0% (derived). Attributable profit CAGR FY2022–FY2025: 84.9% (derived, flattered by FY2025 tax credit).
Embedded value and value metrics
Sources: [IR22] (2021 EV/share), [AR22] (2022), [IR24] (2023), [AR25]. The FY2024 decline in EV/share reflects revised economic assumptions; at end-2025 TPL used a 4.0% investment return and 8.5% risk discount rate, unchanged from end-2024 [AR25]. H1 2026: Group EV/share HK$63.33 (+8.6% YTD); CSM HK$231.4bn; TPL NBV RMB6.268bn (+1.4%); NBV margin 20.1% [IR26].
Balance sheet
Notes: FY2023 total assets approximated from the reported 14.5% FY2024 growth (derived; ~HK$1.5trn reported). FY2023 equity from AR25 equity movement opening balance. Short/long-term split of debt: bank borrowings sit almost entirely in "Other businesses" (financial leasing, holding), with notes spread across life (HK$4.0bn), TPI (HK$3.5bn), reinsurance (HK$1.5bn) and other (HK$7.0bn) at 30 Jun 2026; detailed maturity split not publicly disclosed in results announcements. Net debt is not meaningful for an insurer: reported cash and deposits (HK$132.9bn) exceed interest-bearing debt (HK$77.7bn) at end-2025 (net cash HK$55.2bn, derived), but most cash backs policyholder liabilities. Working capital: NA.
Cash flow
Operating cash flow for a life insurer chiefly reflects net premium inflows ahead of claims and is reinvested; "free cash flow" in the industrial sense overstates distributable cash. Distributable capacity is better gauged through subsidiary dividends to the holdco and solvency headroom.
Trend commentary
Profitability inflection. Profit attributable rose from HK$4.3bn (FY2022 restated) to HK$27.1bn (FY2025) and annualises above HK$25bn on H1 2026. The quality of that growth differs by year: FY2023–FY2024 were driven by insurance service results and favourable bond marks; FY2025 combined a 9.0% higher insurance service result, a 150% higher net investment result and a large one-off tax credit (PAT exceeded PBT by HK$3.2bn); H1 2026 was driven by equity gains (FVPL equities) with a normal tax charge. Investors should treat roughly HK$12–13bn of FY2025 profit as non-recurring tax and mark-to-market benefits (analyst estimate, not company-disclosed).
Top-line stagnation. Insurance revenue has grown only ~1% a year since FY2022 in HK$ terms. Under HKFRS 17 this reflects slow CSM release growth and the deliberate shift to participating products, which carry lower CSM per unit of premium. New business CSM recognised fell 44.2% in FY2025 (HK$11.0bn vs HK$19.7bn), but recovered slightly in H1 2026 (+0.7%) [AR25, IR26].
Capital consumption. The rotation into equities (equity allocation 18.9% at 30 Jun 2026 vs 13.9% at end-2024) and falling bond yields reduced TPL's core solvency from 186% to 128% in 18 months. This is the most important balance-sheet trend: it constrains further equity risk-taking and dividend capacity at TPL, even as reported profits surge.
Leverage discipline. Interest-bearing debt was flat at ~HK$78bn while equity rose, bringing the reported financial leverage ratio down from 26.2% to 21.9%. Repo usage rose sharply in 2025 (HK$106.7bn) to enhance yield, a modest liquidity-risk consideration.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Segment Overview
| Segment | Entities (ownership) | Products/services |
|---|---|---|
Life insurance | TPL (75.1%), TPP life & pension insurance (90%), TPL (HK) (100%) incl. TPL (Macau), TP Singapore life (100%) | Participating, traditional, annuity, long-term health, accident & short-term health, universal, unit-linked; corporate/personal pension insurance; group life |
PRC domestic P&C | TPI (100%) | Motor (incl. NEV), non-marine property, liability, agricultural, health, marine |
Overseas P&C | CTPI (HK) (100%), TP Macau (100%), TP UK (100%), TP Luxembourg (100%), TP Singapore P&C (100%), TP Indonesia (55%) | Commercial and personal lines P&C, cross-border motor, Chinese-enterprise risks |
Reinsurance | TPRe (75%), TPRe (China) (100% of TPRe); TPRB (brokerage) | Life and non-life treaty/facultative reinsurance; catastrophe reinsurance |
Other businesses | TPAM (80%), TPCA (60% TPL/40% TPI), TP Fund (56.3% TPAM/38.5% TPL), TPFH (100%), TPP annuity investment, TSFL (financial leasing), TPIM (property/elder care), TPFS (securities), TPIH (HK), holding company | Asset management, annuity trustee/investment, insurance intermediary, financial leasing, property investment, securities broking |
Life insurance | 1,890,176 | 88,422 |
PRC P&C | 51,318 | 11,990 |
Overseas P&C | 22,114 | 8657 (derived: assets less liabilities) |
Reinsurance | 45,099 | 13,482 |
Other businesses | 133,814 | 46376 (derived) |
Group | 2,167,250 | 175,066 |
Segment insurance revenue (HKD Mn)
| Segment insurance revenue (HKD Mn) | FY2024 | FY2025 |
|---|---|---|
Life insurance | 64,454 | 64,282 |
PRC domestic P&C (TPI) | 33,146 | 34,176 |
Overseas P&C (sum of five operating entities) | 5,984 | 5,767 |
Reinsurance | 8,630 | 8,934 |
Group consolidated insurance revenue | 111,268 | 112,267 |
Segment insurance revenue (HKD Mn) (Half-Yearly)
| Segment insurance revenue (HKD Mn) | H1 2025 | H1 2026 |
|---|---|---|
Life insurance | 32,250 | 33,951 |
PRC domestic P&C (TPI) | 17,128 | 17,972 |
Overseas P&C | 2,771 | 2,822 |
Reinsurance | 4,162 | 4,560 |
Inter-segment elimination | -346 | -378 |
Group consolidated insurance revenue | 55,964 | 58,926 |
Segment profit after tax (HKD Mn)
| Segment profit after tax (HKD Mn) | FY2024 | FY2025 |
|---|---|---|
Life insurance | 10,505 | 34,586 |
PRC domestic P&C | 804 | 966 |
Overseas P&C | 368 | 209 |
Reinsurance | 957 | 1,284 |
Asset management | 539 | 1,450 |
Others (holding, TSFL, consolidation) | -376 | -1,868 |
Net profit from operations | 12,798 | 36,627 |
Non-controlling interests | -4,366 | -9,568 |
Profit attributable to owners | 8,432 | 27,059 |
Segment profit after tax (HKD Mn) (Half-Yearly)
| Segment profit after tax (HKD Mn) | H1 2025 | H1 2026 |
|---|---|---|
Life insurance | 8,278 | 16,682 |
PRC domestic P&C | 686 | 580 |
Overseas P&C | 258 | 364 |
Reinsurance | 872 | 839 |
Asset management | 200 | 532 |
Others | -1,103 | -1,344 |
Net profit from operations | 9,192 | 17,652 |
Profit attributable to owners | 6,764 | 12,873 |
Segment Overview — Life
| Segment | Ins. revenue YoY | Profit YoY | Profit/Ins. revenue | Share of segment profit (ex-Others) | Combined ratio / key metric |
|---|---|---|---|---|---|
Life | -0.3% (+0.3% in RMB) | +229.2% | 53.8% | 89.9% | Insurance service result HK$22.1bn (+12.4%) |
PRC P&C (TPI) | +3.1% | +20.1% | 2.8% | 2.5% | COR 98.8% (2024: 100.1%) |
Overseas P&C | -3.6% | -43.0% | 3.6% | 0.5% | COR range 77.5%–103.4% |
Reinsurance | +3.5% | +34.1% | 14.4% | 3.3% | P&C COR 96.5% (2024: 98.8%) |
Asset management | Fees +19.9% | +168.8% | 40.3% of fee income | 3.8% | AUM HK$2.77trn incl. third party |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Insurance revenue (HKD Mn) | — | 108,906 | 107,489 | 111,268 | 112,267 |
Insurance service result (HKD Mn) | — | — | — | 22,024 | 24,000 |
Net investment result (HKD Mn) | — | — | — | 5,831 | 14,583 |
Total investment income (HKD Mn) | — | — | — | 66,543 | 66,826 |
Profit before tax (HKD Mn) | — | — | — | 22,128 | 33,446 |
Income tax (HKD Mn; positive = credit) | — | — | — | -9,330 | 3,181 |
Profit after tax (HKD Mn) | — | — | — | 12,798 | 36,627 |
Profit attributable to owners (HKD Mn) | 7,514 | 4,297 | 6,190 | 8,432 | 27,059 |
Basic EPS (HKD) | — | — | — | 2.068 | 7.251 |
Diluted EPS (HKD) | — | — | — | 2.068 | 7.251 |
Dividend per share (HKD) | — | 0.26 | 0.30 | 0.35 | 1.23 |
Margin Analysis (%)
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Insurance service margin (ISR / insurance revenue, %) | — | — | 19.8 | 21.4 |
PBT margin on insurance revenue (%) | — | — | 19.9 | 29.8 |
Attributable net margin on insurance revenue (%) | 3.9 | 5.8 | 7.6 | 24.1 |
Attributable profit growth (%) | — | 44.1 | 36.2 | 220.9 |
Insurance revenue growth (%) | — | -1.3 | 3.5 | 0.9 |
Income Statement and Per-Share Data (Half-Yearly)
| Metric | H1 2024 | H1 2025 | H1 2026 |
|---|---|---|---|
Insurance revenue (HKD Mn) | — | 55,964 | 58,926 |
Insurance service result (HKD Mn) | — | 12,316 | 12,876 |
Net investment result (HKD Mn) | — | -535 | 9,694 |
Profit before tax (HKD Mn) | — | 10,262 | 20,536 |
Profit attributable (HKD Mn) | 6,027 | 6,764 | 12,873 |
Basic EPS (HKD) | — | 1.744 | 3.442 |
Annualised total investment yield (%) | — | 2.68 | 5.21 |
Per-Share Data and Key Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Group EV per share attributable to owners (HKD) | 60.54 | 55.11 | 56.51 | 48.57 | 58.30 |
Group EV (HKD Mn) | — | — | — | 234,224 | 280,603 |
TPL EV (HKD Mn) | — | — | — | 206,751 | 244,516 |
TPL NBV (CNY Mn) | — | — | — | 8,430 | 8,661 |
TPL NBV margin (%) | — | — | — | 20.7 | 21.3 |
CSM, group (HKD Mn) | — | — | — | 207,769 | 216,667 |
ROE (%) | — | — | — | 10.0 | 25.5 |
Balance Sheet and Per-Share Data
| Metric | FY2023 | FY2024 | FY2025 | H1 2026 |
|---|---|---|---|---|
Total assets (HKD Mn) | 1,518,000 | 1,734,342 | 1,986,587 | 2,167,250 |
Total investment assets (HKD Mn) | — | 1,562,099 | 1,743,052 | 1,941,507 |
Cash and bank deposits (HKD Mn) | — | 112,712 | 132,894 | 139,478 |
Cash and cash equivalents (HKD Mn) | 42,554 | 44,389 | 54,360 | 54,871 |
Interest-bearing notes (HKD Mn) | — | 10,813 | 13,290 | 16,058 |
Bank borrowings (HKD Mn) | — | 69,872 | 64,406 | 61,564 |
Total interest-bearing debt (HKD Mn) | — | 80,685 | 77,696 | 77,622 |
Repo liabilities (HKD Mn) | — | 46,683 | 106,732 | 91,645 |
Total equity (HKD Mn) | 132,596 | 122,407 | 164,793 | 175,066 |
Ordinary shareholders' equity (HKD Mn) | 78,988 | 71,080 | 95,155 | 103,638 |
Perpetual subordinated securities (HKD Mn) | 15,992 | 15,990 | 15,987 | 15,987 |
Non-controlling interests (HKD Mn) | 37,616 | 35,337 | 53,651 | 55,442 |
Goodwill + intangibles (HKD Mn) | — | 614 | 618 | 627 |
Book value per share (HKD) | — | 19.777 | 26.476 | 28.836 |
Cash Flow
| Metric (HKD Mn) | FY2024 | FY2025 | H1 2025 | H1 2026 |
|---|---|---|---|---|
Net cash from operating activities | 125,949 | 108,830 | 60,681 | 82,309 |
Purchase of property and equipment (capex) | 9,712 | 5,430 | — | — |
Free cash flow proxy (OCF − capex) | 116,237 | 103,400 | — | — |
Net cash used in investing | -95,631 | -101,695 | -71,565 | -80,410 |
Net cash from/(used in) financing | -27,911 | 1,785 | 8,056 | -3,026 |
Dividends paid to shareholders | 1,078 | 1,258 | — | — |
Dividends paid to NCI | 1,080 | 1,206 | — | — |
Share buybacks | 0 | 0 | 0 | 0 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2024 | FY2025 | Basis |
|---|---|---|---|
ROE (reported, %) | 10.0 | 25.5 | [AR25] |
ROA (PAT / average total assets, %) | 0.79 | 1.97 | derived |
ROA (attributable profit / average total assets, %) | 0.52 | 1.45 | derived |
Financial leverage ratio (reported, %) | 26.2 | 23.2 | debt / (debt + ordinary equity + after-tax CSM) [AR25]; H1 2026: 21.9% |
Interest-bearing debt / ordinary equity (%) | 113.5 | 81.7 | derived |
Interest coverage ((PBT + finance costs) / finance costs, x) | 7.4 | 14.6 | derived; other finance costs HK$3.46bn / HK$2.47bn |
Asset turnover (insurance revenue / avg assets, %) | 6.8 | 6.0 | derived |
Dividend payout (DPS / basic EPS, %) | 16.9 | 17.0 | derived |
Net investment yield (%) | 3.46 | 3.21 | [AR25] |
Total investment yield (%) | 4.57 | 4.04 | [AR25] |
Comprehensive investment yield (%) | 10.32 | 1.73 | [AR25]; 4.29% ex-FVOCI bond fair-value changes |
Margin Analysis (%) (FY2024–H1 2026)
| Ratio (%) | FY2024 | FY2025 | H1 2026 |
|---|---|---|---|
TPL core solvency | 186 | 143 | 128 |
TPL comprehensive solvency | 298 | 230 | 215 |
TPI core solvency | 172 | 170 | 171 |
TPI comprehensive solvency | 239 | 236 | 240 |
TPP core solvency | 186 | 160 | 155 |
TPP comprehensive solvency | 245 | 215 | 212 |
Geography — share of total income (%)
| Geography — share of total income (%) | H1 2025 | H1 2026 |
|---|---|---|
Mainland China | 89 | 92 |
Hong Kong, Macau and rest of world | 11 | 8 |
Geographic Revenue
| Region | FY2025 | H1 2026 |
|---|---|---|
Hong Kong and Macau | 11,949 | 11,845 |
Mainland China | 56,404 | 56,461 |
Rest of world | 756 | 784 |
Group Entities
| Entity (geography) | FY2024 ins. revenue (HKD Mn) | FY2025 ins. revenue (HKD Mn) | YoY | FY2025 direct premium (HKD Mn) |
|---|---|---|---|---|
TPL (Mainland life) | — | — | +3.2% (RMB) | 201,408 |
TPP (Mainland pensions/life) | — | — | — | 6,620 |
TPI (Mainland P&C) | 33,146 | 34,176 | +3.1% | 35,455 |
TPL (HK) (Hong Kong/Macau life) | — | — | — | 12,826 |
TP Singapore life | — | — | — | 995 |
CTPI (HK) | 3,313 | 3,042 | -8.2% | 2,509 |
TP Macau | 929 | 922 | -0.8% | 956 |
TP UK | 309 | 275 | -10.9% | 443 |
TP Singapore P&C | 821 | 888 | +8.1% | 874 |
TP Indonesia | 611 | 641 | +4.8% | 631 |
TPRe (HK + China; global) | 8,630 | 8,934 | +3.5% | 16261 (total premium) |
Revenue by Region
| Direct premium (HKD Mn) | FY2024 | FY2025 | H1 2026 |
|---|---|---|---|
TPL | 195,867 | 201,408 | 133,025 |
TPP | 8,844 | 6,620 | 1,665 |
TPL (HK) | 15,081 | 12,826 | 5,985 |
TP Singapore life | 779 | 995 | 426 |
TPI | 34,297 | 35,455 | 20,480 |
CTPI (HK) | 2,606 | 2,509 | 1,378 |
TP Macau | 924 | 956 | 515 |
TP UK | 418 | 443 | 206 |
TP Singapore P&C | 792 | 874 | 433 |
TP Indonesia | 611 | 631 | 403 |
Revenue by Region (FY2025–H1 2026)
| GBA metric | FY2025 | H1 2026 |
|---|---|---|
Premium income (HKD Mn; 9 GBA cities + HK + Macau) | 55,976 | — |
Investment scale (HKD Mn) | 111,500 | 123,300 |
Valuation Snapshot
| Metric | Value | Source/derivation |
|---|---|---|
Share price | ≈HK$19.49 (latest Stockopedia close); HK$20.28 (15 Aug 2026); HK$22.02 (31 Jul 2026) | [MKT] |
52-week range | HK$14.18 – HK$25.96 | [MKT, Aug 2026] |
1-year price change | ≈+25% (as of early Aug 2026) | [MKT] |
Relative performance | Underperformed FTSE Developed Asia Pacific by 25.5% over one year and 34.7% over six months (latest Stockopedia) | [MKT] |
Market capitalisation | ≈HK$70.0bn | 3,594.0m shares × HK$19.49 |
Trailing P/E (FY2025 EPS HK$7.251) | 2.7x | derived |
P/E on TTM EPS (HK$8.949 = 7.251 − 1.744 + 3.442) | 2.2x | derived |
P/B (BVPS HK$28.836, Jun 2026) | 0.68x | derived |
P/EV (Group EV/share HK$63.33, Jun 2026) | 0.31x | derived |
Dividend yield (HK$1.23) | 6.3% | derived |
EV/EBITDA, EV/Sales | Not meaningful for insurer | — |
Source Details
| Source | Rating / target | Date |
|---|---|---|
Google Finance aggregation | 9 Buy / 1 Hold; average target HK$28.59 (range HK$25.00–33.10) | Jun 2026 |
Investing.com aggregation | Average target HK$25.12 (range HK$15–33.1) | Aug 2026 |
Stockopedia | Consensus target HK$25.78; next-year EPS forecast HK$3.99 | Latest |
CICC | Outperform, TP HK$33.1 | 26 Mar 2026 |
GF Securities | Buy, TP HK$29.34 (0.45x P/EV) | 27 Mar 2026 |
Per-Share Data and Dividends & Capital Returns
| Metric | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Final DPS (HKD) | 0.26 | 0.30 | 0.35 | 1.23 |
Total dividend (HKD Mn) | — | 1,078 | 1,258 | 4,421 |
Payout on basic EPS (%) | — | — | 16.9 | 17.0 |
Credit Ratings
| Agency | Entity | Rating | Outlook | Date / note |
|---|---|---|---|---|
Fitch | CTIH IDR | "A-" (per Nov 2025 press headline; earlier "A" before 2025 sovereign-linked downgrade) | — | Affirmed Nov 2025; consolidated credit quality raised to "a" from "a-" |
Fitch | TPL IFS / TPRe IFS | — | — | — |
AM Best | CTPI (HK) | FSR A (Excellent); ICR "a" | Stable | Dec 2025 |
AM Best | TP Macau (CTIM) | FSR A; ICR "a" | Stable | Mar 2026 |
AM Best | TPRe & TPRe (China) | — | — | — |
Moody's | CTIH | — | — | — |
S&P | CTIH | — | — | — |
Capital Instruments
| Instrument | Amount | Maturity / call |
|---|---|---|
CTIH perpetual subordinated capital securities | US$2bn (HK$15.99bn carrying) | Non-call to 2028; 6.4% initial distribution |
Subsidiary perpetual capital securities | HK$9.75bn (in NCI) | — |
Interest-bearing notes | HK$16.06bn (Jun 2026) | Maturity ladder not publicly disclosed in results |
Bank borrowings | HK$61.56bn (Jun 2026) | Mostly leasing/holdco; ladder not publicly disclosed in results |
Finance lease receivables (asset side match) | HK$45.6bn undiscounted; HK$14.1bn due <1 year | [IR26 Note 18] |
Analyst Conclusions
Management guidance
Qualitative only: steadfastly pursue high-quality development; "qualitative enhancement and quantitative growth at a reasonable pace"; deepen value transformation; strengthen ALM against low rates; increase high-quality equity allocations; prudent internationalisation; AI-driven efficiency [AR25, IR26]. No numerical targets.
Consensus expectations
Consensus next-year EPS of HK$3.99 (Stockopedia) appears stale relative to H1 2026 EPS of HK$3.442; consensus data quality is low and likely to be revised. Analyst targets cluster around HK$25–29, implying 30–50% upside.
Bull case
-
Deep value with improving earnings quality: at 0.31x P/EV and 2.2x TTM P/E, the market prices in severe value destruction even though EV/share has grown from HK$48.57 to HK$63.33 in 18 months.
-
Peer catch-up on NBV: the participating transition is essentially complete (97.8%), so the mix headwind that suppressed 2024–25 NBV should fade; agent productivity +73.8% and first-year premium +10.6% hint at a 2026–27 NBV inflection.
-
Dividend upside: a 17% payout on a ~HK$25bn earnings base leaves room for higher distributions, especially if TPL solvency stabilises and holdco cash builds.
Bear case
-
Earnings are market beta, not franchise growth: FY2025 relied on a one-off tax credit and H1 2026 on equity gains; insurance revenue has barely grown and net investment yield is falling toward 2.85%.
-
Capital squeeze: TPL core solvency at 128% and falling limits further equity risk and dividend growth; a market downturn would hit both profit and solvency simultaneously.
-
Governance and leakage discount is structural: policy mandates, ~26% minority leakage and limited capital-return tools (no buybacks) may keep the stock at a permanent discount.
Catalysts and monitorables (next 12 months)
| Catalyst / monitorable | Timing | What to watch |
|---|---|---|
| 9M/Q3 2026 subsidiary solvency disclosures | Late Oct 2026 | TPL core solvency trend vs. 128% |
| Chinese equity market and 10-year CGB yield | Continuous | FVPL equity P&L; reinvestment yields |
| Profit alert for FY2026 | Jan 2027 | Magnitude vs. FY2025 (tax-adjusted) |
| FY2026 results and dividend | Late Mar 2027 | NBV growth, DPS vs. HK$1.23, EV assumptions |
| EV assumption review | FY2026 | Any cut to 4.0% investment return / 8.5% RDR |
| 15th Five-Year Plan group strategy | 2026–27 | Any quantified targets |
| Capital actions | Any time | Holdco or TPL capital raising; perpetual issuance; 2028 call planning |
| Rating actions | Any time | Fitch/AM Best; sovereign linkage |
| Board composition | Ongoing | INED refresh; audit committee strength |
| Hong Kong catastrophe season | Jun–Oct | CTPI (HK), TPRe loss experience |
Analyst verdict
China Taiping enters late 2026 with the best reported earnings in its history and the weakest relative valuation among major Chinese life insurers—a combination that demands careful decomposition rather than reflexive optimism. The headline numbers are genuine but heterogeneous. FY2025's HK$27.1bn profit owed a large share to a one-off tax credit; H1 2026's HK$12.9bn owed much to a rebound in domestic equities that the Group positioned for by lifting equity allocation to 18.9%. Neither driver is a durable franchise improvement, and both have a cost: TPL's core solvency has fallen 58 points in 18 months.
The underlying franchise tells a more nuanced story. Persistency is excellent, the participating transition is complete, CSM is growing again (+6.8% YTD), and agent productivity has nearly doubled. These are the preconditions for a recovery in new business value, which has trailed peers by roughly 30 percentage points of growth. If 2027 shows NBV growth converging toward the industry, the valuation gap—0.31x EV against an EV/share that has compounded rapidly—becomes hard to justify.
Against that, the stock's discount reflects real structural factors: dependence on a single rate-sensitive Mainland life subsidiary, minority leakage to Ageas and perpetual holders, policy objectives set by a state shareholder, a low payout, and the absence of buybacks. Falling domestic yields remain the dominant long-term threat, and the 4.0% EV return assumption sits well above the 2.85% current net investment yield.
Our synthesis: CTIH is a high-beta, deep-value play on Chinese equity markets and rate stabilisation, with an optional upside from NBV normalisation and dividend growth. The key confirming signals are stabilising TPL solvency, positive NBV momentum in FY2026, and a further dividend increase; absent these, the discount is likely to persist regardless of reported earnings.
End of dossier. Figures from company filings unless otherwise stated; derived metrics are analyst calculations.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed (CTIH) | Background | Age (at appointment) |
|---|---|---|---|---|
YIN Zhaojun | Chairman, Executive Director | — | Chairman of TPG; chairs multiple subsidiaries | — |
LI Kedong | Vice Chairman, General Manager, Executive Director | ED and deputy GM earlier; Vice Chairman & GM from 23 Jan 2025 | Previously deputy GM of TPG and TPG (HK); career at China Export & Credit Insurance Corp. (Sinosure) incl. GM of Shanghai and Guangdong branches, HR and product departments; earlier at Civil Aviation Administration of China general office | 57 (Jan 2025) |
NA Yanfang | Executive Director | 25 Sep 2025 | Executive director of TPG; member of NRC, risk management and strategy & investment committees | 52 |
ZHOU Lianggang | Non-executive Director | 24 Mar 2025 | Non-executive director of TPG; formerly deputy director-general of Chongqing Local Tax Bureau and deputy director of Chongqing Municipal Tax Services | 54 |
FENG Zhanwu | Non-executive Director | 21 Nov 2025 | Non-executive director of TPG; formerly deputy director-general level cadre of Beijing National Accounting Institute | 52 |
LIU Yi | Independent NED | — | Audit committee member (from Jun 2026) | — |
SHIU Sin Por | Independent NED | — | Former Hong Kong government policy official (Central Policy Unit head) | — |
CAI Hongping | Independent NED | — | Investment banking background | — |
CHAN Ching Har Eliza | Independent NED | 25 Aug 2026 | — | — |
“—” = not publicly disclosed.
Board & Management Changes
| Date | Change | Context |
|---|---|---|
23 Jan 2025 | LI Kedong appointed Vice Chairman and GM; YIN Zhaojun left risk management committee | New management team |
24 Mar 2025 | ZHOU Lianggang appointed NED | TPG nominee |
2025 (H1) | YIN and LI assumed chairmanships at multiple subsidiaries | Strategic coordination |
Mar–Sep 2025 | ~15 senior appointments across subsidiaries (e.g., LI Wei interim head of Taiping Technology; TANG Xinan returned as TPL Assistant GM; CHEN Xiang Assistant GM of Taiping Technology) | Largest reshuffle in years |
25 Sep 2025 | NA Yanfang appointed ED; YIN left NRC | Governance refresh |
21 Nov 2025 | NEDs GUO Zhaoxu and one other resigned; FENG Zhanwu appointed NED | TPG nominee rotation |
24 Apr 2026 | NED HU Xingguo resigned (retirement age) | Left audit and strategy committees |
23 Jun 2026 | INED Mrs LAW FAN Chiu Fun Fanny resigned | Other commitments; LIU Yi joined audit committee |
25 Aug 2026 | CHAN Ching Har Eliza appointed INED | Restores INED count |
Major Shareholders
| Holder | Stake |
|---|---|
China Taiping Insurance Group Ltd. (via TPG (HK)) | ≈59% |
Southbound Stock Connect investors (aggregate) |
|
Competitive Landscape
Competitors by Segment
| Segment | Competitors |
|---|---|
Mainland life | China Life (2628.HK/601628.SS), Ping An Life (Ping An 2318.HK), CPIC Life (2601.HK), New China Life (1336.HK), Taikang Life (unlisted), PICC Life (PICC Group 1339.HK), Sunshine Life (6963.HK), China Post Life (unlisted) |
Mainland P&C | PICC P&C (2328.HK), Ping An P&C, CPIC P&C, China United, Sunshine P&C, ZhongAn (6060.HK) |
Pensions | China Life Pension, Ping An Pension, Changjiang Pension (CPIC), Taikang Pension |
HK/Macau life & P&C | AIA (1299.HK), Prudential, Manulife, FWD, HSBC Life, BOC Life, China Life (Overseas) |
Reinsurance | China Re (1508.HK), Swiss Re, Munich Re, Hannover Re, SCOR |
Asset management | China Life AMC, Ping An AMC, CPIC AMC, Taikang AMC |
Peer Comparison FY2025
| Metric | CTIH | China Life | Ping An |
|---|---|---|---|
Net profit attributable FY2025 | HK$27.06bn (+220.9%) | RMB154.08bn (+44.1%) | — |
Life NBV FY2025 | RMB8.66bn (+2.7%) | RMB45.75bn (+35.7%) | RMB36.90bn (+29.3%) |
NBV margin FY2025 | 21.3% | — | 28.5% |
Life market share | 4.2% (TPL) | — | — |
Recent Developments
Layoffs: headcount fell 4,621 YoY to 57,205 at 30 Jun 2026 (no formal layoff programme disclosed).



